文献速递生殖医学产科

共享母亲IVF与供精人工授精的女同性伴侣围产结局比较

Perinatal outcomes in lesbian couples employing shared motherhood IVF compared with those performing artificial insemination with donor sperm.
PubMed 文献 · Hum Reprod · 2023-01-01

回顾性研究比较660个共享母亲IVF(SMI)周期(299例妊娠)与4349个供精人工授精(AID)周期(949例妊娠)的围产结局。单胎妊娠中SMI与AID结局非常相似,仅SMI的子痫前期/高血压(PE/HT)率有非显著升高(受者年龄校正OR=1.9,95%CI=0.7-5.2,P=0.19);双胎SMI妊娠的PE/HT频率远高于AID双胎(受者年龄校正OR=21.7,95%CI=2.8-289.4,P=0.01)。

要点

  • 单胎SMI与AID围产结局非常相似,仅PE/HT有非显著升高趋势(校正OR=1.9,95%CI=0.7-5.2)。
  • 双胎SMI妊娠的PE/HT风险远高于AID双胎(校正OR=21.7,95%CI=2.8-289.4,P=0.01)。
  • SMI妊娠率高于AID(45.3% vs 21.8%,P<0.001)。

核心结论

  • SMI单胎妊娠与AID单胎妊娠的围产结局非常相似。
  • SMI双胎妊娠的PE/HT频率远高于AID双胎(受者年龄校正OR=21.7,95%CI=2.8-289.4,P=0.01)。
  • SMI若行单胚胎移植似乎是安全的手术,不应进行双胚胎移植。
  • 作者认为OD的多数并发症可能与受者状态而非OD本身更相关,因SMI的围产并发症远低于通常描述的OD。

研究设计与样本

  • 回顾性研究,纳入10年间17家西班牙同一集团诊所中女同性伴侣的660个SMI周期(299例妊娠)和4349个AID周期(949例妊娠)。
  • 比较SMI与AID的妊娠率及围产结局:孕周、新生儿体重、早产和低出生率、PE/HT率、剖宫产率、围产死亡和新生儿畸形。

主要发现

  • SMI妊娠率高于AID(45.3% vs 21.8%,P<0.001)。
  • AID多胎率有非显著升高趋势(4.7% vs 8.5%,P=0.08)。
  • 单胎中SMI与AID的孕周(278天(268-285) vs 279天(272-284),P=0.24)、早产率(8.3% vs 7.3%,P=0.80)、<28周早产(0.6% vs 0.4%,P=1.00)、新生儿体重(3195 g(2915-3620) vs 3270 g(2980-3600),P=0.296)、低出生率(6.4% vs 6.4%,P=1.00)、极低出生体重(0.6% vs 0.5%,P=1.00)及体重分组分布均无差异。
  • 单胎中SMI与AID的剖宫产率、新生儿畸形率和围产死亡率相似。
  • 单胎中SMI的PE/HT有非显著升高趋势(受者年龄校正OR=1.9,95%CI=0.7-5.2,P=0.19)。

关键数值与推荐

  • SMI单胎PE/HT:受者年龄校正OR=1.9,95%CI=0.7-5.2,P=0.19。
  • SMI双胎PE/HT:受者年龄校正OR=21.7,95%CI=2.8-289.4,P=0.01。
  • SMI妊娠率45.3% vs AID 21.8%,P<0.001。
  • SMI多胎率4.7% vs AID 8.5%,P=0.08。

临床怎么用

  • 作者认为SMI若行单胚胎移植似乎是安全的手术。
  • 作者建议SMI不应进行双胚胎移植。

局限性

  • 妊娠过程数据来自分娩报告登记及患者自述,不能排除一定程度的不准确。
  • 部分参数数据缺失高达10%。
  • 因SMI与AID报告方法相同,不应预期存在差异性报告偏倚。
  • 不能排除在更大规模研究中单胎妊娠的PE/HT风险会显著。
  • SMI组分配移植2枚胚胎非随机化,可能存在偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: In lesbian couples, is shared motherhood IVF (SMI) associated with an increase in perinatal complications compared with artificial insemination with donor sperm (AID)? SUMMARY ANSWER: Singleton pregnancies in SMI and AID had very similar outcomes, except for a non-significant increase in the rate of preeclampsia/hypertension (PE/HT) in SMI (recipient's age-adjusted odds ratio (OR) = 1.9, 95% CI = 0.7-5.2; P = 0.19), but twin SMI pregnancies had a much higher frequency of PE/HT than AID twins (recipient's age-adjusted OR = 21.7, 95% CI = 2.8-289.4; P = 0.01). WHAT IS KNOWN ALREADY: Oocyte donation (OD) pregnancies are associated with an increase in perinatal complications, in particular, preterm delivery and low birth weight, and PE/HT. However, it is unclear to what extent these complications are due to OD process or to the conditions why OD was performed, such as advanced age and underlying health conditions. Unfortunately, the literature concerning perinatal outcomes in SMI is scarce. STUDY DESIGN, SIZE, DURATION: Retrospective study involving 660 SMI cycles (299 pregnancies) and 4349 AID cycles (949 pregnancies) assisted over a 10-year period. PARTICIPANTS/MATERIALS, SETTING, METHODS: All cycles fulfilling the inclusion criteria performed in lesbian couples seeking fertility treatment in 17 Spanish clinics of the same group. Pregnancy rates of SMI and AID cycles were compared. Perinatal outcomes were compared: gestational length, newborn weight, preterm and low birth rates, PE/HT rates, cesarean section rates, perinatal mortality, and newborn malformations. MAIN RESULTS AND THE ROLE OF CHANCE: Pregnancy rates were higher in SMI than in AID (45.3% versus 21.8%, P < 0.001). There was a non-significant trend to higher multiple rate in AID (4.7% versus 8.5%, P = 0.08). In single pregnancies, there were no differences between SMI and AID in gestational age (278 days (268-285) versus 279 (272-284), P = 0.24), preterm rate (8.3% versus 7.3%, P = 0.80), preterm <28 weeks (0.6% versus 0.4%, P = 1.00), newborn weight (3195 g (2915-3620) versus 3270 g (2980-3600), P = 0.296), low birth rate (6.4% versus 6.4%, P = 1.00), extremely low birth weight (0.6% versus 0.5%, P = 1.00), and the distribution of newborns by weight groups. Cesarean section rate, newborn malformation rate, and perinatal mortality were also similar in SMI and AID. Additionally, there was non-significant trend in hypertensive disorders to an increase in PE/HT among SMI (recipient's age-adjusted OR = 1.9, 95% CI = 0.7-5.2). Overall, perinatal data are consistent with what is reported in the general population. In twin pregnancies, the aforementioned perinatal parameters were also very similar in SMI and AID. However, SMI twin pregnancies had a very high risk of PE/HT when compared with AID (recipient's age-adjusted OR = 21.7, 95% CI = 2.8-289.4, P = 0.01). LIMITATIONS, REASONS FOR CAUTION: Our data regarding the pregnancy course were obtained from information registered in the delivery report as well as from what was reported by the patients themselves, so a certain degree of inaccuracy cannot be ruled out. Additionally, in some parameters, there was up to 10% of data missing. However, since the methodology of reporting was the same in SMI and AID groups, one should not expect a differential reporting bias. It cannot be ruled out that the risk of PE/HT in simple gestations would be significant in a larger study. Additionally, in the SMI group allocation to the transfer of 2 embryos was not randomized so some bias is possible. WIDER IMPLICATIONS OF THE FINDINGS: SMI, if single embryo transfer is performed, seems to be is a safe procedure. Double embryo transfer should not be performed in SMI. Our data suggest that the majority of complications in OD could be related more with recipient status than with OD itself, since with SMI (performed in women without fertility problems) the perinatal complications were much lower than usually described in OD. STUDY FUNDING/COMPETING INTEREST(S): No external funding was received. The authors declare that they have no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Matorras R, Perez-Fernandez S, Hubel A, et al. Perinatal outcomes in lesbian couples employing shared motherhood IVF compared with those performing artificial insemination with donor sperm. Hum Reprod. 2023. PMID: 37009817. doi:10.1093/humrep/dead035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。